Piramal Enterprises is one of India’s largest diversified companies, with a presence in pharmaceutical, financial services and information management sectors. Piramal Enterprises had consolidated revenues of over $ 650 million in FY2013. In the pharmaceutical space, PEL is one of leading custom manufacturing player globally, has presence in the global critical care segment with a portfolio of inhalation and injectible anesthetics and its OTC business is ranked no. 7 in India. PEL is also engaged in drug discovery & research and has strong pipeline of development products. In the financial services space, PEL has a real estate focused PE fund – Indiareit and a NBFC that is focused on lending to real estate, education & infrastructure sector. PEL’s healthcare information management business, Decision Resources Group is a leading provider of information based services to the healthcare industry.
Piramal | Healthcare
We have manufacturing bases across India, UK, Scotland, USA and Canada. Our critical care products are available in the emergency rooms of most hospitals across the globe and our products are available in over 100 countries. We are presently the third largest player in the global Inhalation Anesthesia (IA) market, and the only company in the world with a complete product portfolio of inhalation anesthetics drugs.
Our custom manufacturing capabilities make us one of the largest custom manufacturing companies in the world. The UN Conference on Trade and Development’s World Investment Report 2011 ranks us among the top 5 in the world.
Through the years, we at Piramal | Healthcare have partnered with the largest and most reputed organisations in the global pharmaceutical industry to expand our product offering and deliver the best innovations to our customers.
Piramal | Life Sciences
We are a team of over 400 scientists spread across the globe engaged in the search for novel and innovative medical solutions. At Piramal | Life Sciences, we have dedicated ourselves to modern medicine and have over 295 issued patents plus 808 pending patent applications. These are spread across various categories such as compositions of matter, methods of treatments, biomarkers, diagnostics, pharmaceutical compositions and drug delivery systems.
Piramal | Capital
Piramal | Capital is the financial services unit of Piramal Enterprises and comprises three entities – Piramal Finance, the non-banking financial company (NBFC) which provides debt funding support for real estate, education related infrastructure, hospital projects and medical equipment. The second is Structured Investments Group which focuses on funding of infrastructure projects over USD 100 million. And the third is Indiareit Fund Advisors, which is our real estate venture capital fund and is one of the most successful real estate private equity funds in India we manage assets (AUMs) of over USD 1 billion.
Decision Resources Group
Piramal Enterprises’ entry into the healthcare information management space was marked by the acquisition of Decision Resources Group in May 2012 for USD 635 million.
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. DRG is led by an analyst force of over 200 MDs, PhDs, pharmacists and management professionals who draw information from a network of 125,000 physicians to provide detailed insights for DRG’s customers. DRG is primarily focused on providing information products within the bio-pharmaceutical and medical technology sectors, which together represent a $2.5 billion dollar market opportunity.